Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Regression of drug-resistant lung cancer by the combination of rosiglitazone and carboplatin.

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.